UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000043959 |
|---|---|
| Receipt number | R000050207 |
| Scientific Title | Prevalence and prognostic implication of sarcopenia among patients with stage B heart failure |
| Date of disclosure of the study information | 2021/06/01 |
| Last modified on | 2025/05/09 11:47:51 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2021/04/18 00:17:02 | ||
| 2 | Update | 2021/04/26 15:09:22 | Public title Public title Acronym Acronym Scientific Title Scientific Title Scientific Title:Acronym Scientific Title:Acronym |
|
| 3 | Update | 2021/04/26 15:13:07 | Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
| 4 | Update | 2021/04/26 15:17:34 | Co-sponsor Co-sponsor |
|
| 5 | Update | 2021/04/26 15:18:11 | Target sample size |
|
| 6 | Update | 2021/04/26 15:53:43 | ||
| 7 | Update | 2021/04/27 10:23:11 | Acronym Acronym Scientific Title:Acronym Scientific Title:Acronym |
|
| 8 | Update | 2021/04/27 10:25:34 | Public title Scientific Title |
|
| 9 | Update | 2021/04/27 13:28:42 | Co-sponsor Co-sponsor |
|
| 10 | Update | 2021/04/27 13:31:11 | Public title Scientific Title |
|
| 11 | Update | 2021/04/27 13:31:52 | Scientific Title |
|
| 12 | Update | 2021/04/27 13:32:36 | Target sample size |
|
| 13 | Update | 2021/04/27 13:33:10 | Middle name of lead principal investigator |
|
| 14 | Update | 2021/04/27 13:34:04 | Other related information Other related information |
|
| 15 | Update | 2021/04/27 14:55:15 | Public title Acronym Acronym Scientific Title Scientific Title:Acronym Scientific Title:Acronym |
|
| 16 | Update | 2021/04/27 15:04:58 | Public title Acronym Scientific Title Scientific Title:Acronym |
|
| 17 | Update | 2021/04/30 18:37:20 | Co-sponsor Co-sponsor |
|
| 18 | Update | 2021/05/22 20:06:50 | Public title Acronym Acronym Scientific Title Scientific Title:Acronym Scientific Title:Acronym |
|
| 19 | Update | 2021/05/22 20:11:23 | Narrative objectives1 Narrative objectives1 Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
| 20 | Update | 2021/05/22 20:15:51 | Key exclusion criteria Key exclusion criteria Target sample size |
|
| 21 | Update | 2021/05/22 20:18:11 | Co-sponsor Co-sponsor |
|
| 22 | Update | 2021/05/22 20:23:15 | Date of IRB Last follow-up date Other related information Other related information |
|
| 23 | Update | 2021/06/25 16:02:02 | Public title Scientific Title |
|
| 24 | Update | 2021/06/25 18:03:12 | Recruitment status Other related information Other related information |
|
| 25 | Update | 2021/07/13 18:31:43 | Public title Scientific Title |
|
| 26 | Update | 2021/07/13 18:34:28 | Key exclusion criteria Key exclusion criteria |
|
| 27 | Update | 2021/07/13 18:50:01 | Co-sponsor Co-sponsor Institutions |
|
| 28 | Update | 2021/07/13 19:02:05 | Other related information Other related information |
|
| 29 | Update | 2021/11/05 16:19:27 | Institutions |
|
| 30 | Update | 2021/11/05 16:23:43 | Other related information Other related information |
|
| 31 | Update | 2024/06/12 15:46:21 | Recruitment status |
|
| 32 | Update | 2024/06/12 15:47:02 | Number of participants that the trial has enrolled |
|
| 33 | Update | 2025/05/09 11:47:51 | Other related information |
